Countermeasures and Preparedness Products

Description

The UK Health Security Agency (UKHSA) intends to establish a Framework Agreement for the provision of Countermeasures and Preparedness products (the “Framework Agreement”). The Framework Agreement will be available for use by UKHSA and potentially other eligible public sector organisations such as the Ministry of Defence (MOD). The Framework Agreement will provide access to a range of pre-approved suppliers and their products. At this stage, it is intended that the Framework Agreement will comprise multiple lots including, but not limited to: - Antivirals - Antibiotics - Antitoxins - Antivenoms - Antidotes - Vaccines - Immunoglobulins - Intravenous Fluids (IV's) - ICU Medicines - Radiation Treatments - Medical Consumables (used in administering the medicines)* - Combined Needles and Syringes* *For the purposes of preliminary market engagement, we have included all products in scope of our portfolio. To confirm, recently awarded contracts will continue for their term.  The proposed scope and lotting structure will be explored further during the preliminary market engagement, with the final lotting structure confirmed in the UK 4 Tender Notice for this procurement. Suppliers will be awarded places on the Framework Agreement based on their ability to meet quality standards and deliver value for money. UKHSA is committed to working with suppliers who support Sustainability and Social Value objectives, and these elements are expected to form part of the award criteria, details of which will be set out in the tender documentation.